• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Current status of arterial grafts for coronary artery bypass grafting.冠状动脉旁路移植术用动脉移植物的现状。
Ann Cardiothorac Surg. 2013 Jul;2(4):427-30. doi: 10.3978/j.issn.2225-319X.2013.07.21.
2
No improvements in long-term outcome after coronary artery bypass grafting with arterial grafts as a second conduit: a Swedish nationwide registry study.冠状动脉旁路移植术使用动脉移植物作为第二根血管后,长期预后并无改善:一项瑞典全国登记研究。
Eur J Cardiothorac Surg. 2018 Feb 1;53(2):448-454. doi: 10.1093/ejcts/ezx280.
3
Patency of conduits in patients who received internal mammary artery, radial artery and saphenous vein grafts.接受内乳动脉、桡动脉和隐静脉移植物的患者的管道通畅情况。
BMC Cardiovasc Disord. 2020 Mar 24;20(1):148. doi: 10.1186/s12872-020-01433-0.
4
Excellent patency and growth potential of internal mammary artery grafts in pediatric coronary artery bypass surgery. New evidence for a "live" conduit.小儿冠状动脉搭桥手术中乳内动脉移植物的出色通畅率和生长潜力。关于“活体”管道的新证据。
Circulation. 1988 Sep;78(3 Pt 2):I129-39.
5
The no-touch saphenous vein as the preferred second conduit for coronary artery bypass grafting.首选非接触式隐静脉作为冠状动脉旁路移植术的第二移植物。
Ann Thorac Surg. 2013 Jul;96(1):105-11. doi: 10.1016/j.athoracsur.2013.01.102. Epub 2013 May 16.
6
Radial artery for coronary artery bypass grafting: does proximal anastomosis to the aorta or left internal mammary artery achieve better patency?用于冠状动脉搭桥术的桡动脉:与主动脉或左乳内动脉进行近端吻合,哪种方式的通畅性更好?
Interact Cardiovasc Thorac Surg. 2013 Dec;17(6):1020-4. doi: 10.1093/icvts/ivt346. Epub 2013 Aug 23.
7
The radial artery: current concepts on its use in coronary artery revascularization.桡动脉:在冠状动脉血运重建中的应用的最新观念。
Ann Thorac Surg. 2013 Nov;96(5):1900-9. doi: 10.1016/j.athoracsur.2013.06.083. Epub 2013 Oct 3.
8
Fractional flow reserve-guided coronary artery bypass grafting: can intraoperative physiologic imaging guide decision making?分数血流储备指导下的冠状动脉旁路移植术:术中生理成像能指导决策吗?
J Thorac Cardiovasc Surg. 2013 Oct;146(4):824-835.e1. doi: 10.1016/j.jtcvs.2013.06.026. Epub 2013 Aug 1.
9
Survival and graft patency after coronary artery bypass grafting with coronary endarterectomy: role of arterial versus vein conduits.冠状动脉内膜切除术冠状动脉搭桥术后的生存情况及移植血管通畅率:动脉与静脉移植物的作用
Ann Thorac Surg. 2007 Jul;84(1):25-31. doi: 10.1016/j.athoracsur.2007.02.053.
10
Assessing the Long-term Patency and Clinical Outcomes of Venous and Arterial Grafts Used in Coronary Artery Bypass Grafting: A Meta-analysis.评估冠状动脉旁路移植术中使用的静脉和动脉移植物的长期通畅率及临床结局:一项荟萃分析。
Cureus. 2019 Sep 16;11(9):e5670. doi: 10.7759/cureus.5670.

引用本文的文献

1
Inflammatory Markers and Saphenous Vein Graft Stenosis: Insights into the Use of Glucose-to-Lymphocyte Ratio as a Prognostic Marker.炎症标志物与大隐静脉移植血管狭窄:关于葡萄糖与淋巴细胞比值作为预后标志物应用的见解
J Clin Med. 2025 Apr 11;14(8):2634. doi: 10.3390/jcm14082634.
2
Histological assessment of a novel restorative coronary artery bypass graft in a chronic ovine model.在慢性绵羊模型中对一种新型冠状动脉搭桥修复移植物的组织学评估。
Front Bioeng Biotechnol. 2025 Feb 10;13:1488794. doi: 10.3389/fbioe.2025.1488794. eCollection 2025.
3
Saphenous Vein Graft Failure: Current Challenges and a Review of the Contemporary Percutaneous Options for Management.大隐静脉移植血管失败:当前挑战及当代经皮治疗选择综述
J Clin Med. 2023 Nov 15;12(22):7118. doi: 10.3390/jcm12227118.
4
Bilayer vascular grafts with on-demand NO and HS release capabilities.具有按需释放一氧化氮和硫化氢能力的双层血管移植物。
Bioact Mater. 2023 Aug 8;31:38-52. doi: 10.1016/j.bioactmat.2023.07.020. eCollection 2024 Jan.
5
Comparison of the Patency and Regenerative Potential of Biodegradable Vascular Prostheses of Different Polymer Compositions in an Ovine Model.不同聚合物组成的可生物降解血管假体在羊模型中的通畅性和再生潜力比较。
Int J Mol Sci. 2023 May 10;24(10):8540. doi: 10.3390/ijms24108540.
6
Basement Membrane of Tissue Engineered Extracellular Matrix Scaffolds Modulates Rapid Human Endothelial Cell Recellularization and Promote Quiescent Behavior After Monolayer Formation.组织工程细胞外基质支架的基底膜调节人内皮细胞快速再细胞化,并在单层形成后促进静止行为。
Front Bioeng Biotechnol. 2022 Aug 2;10:903907. doi: 10.3389/fbioe.2022.903907. eCollection 2022.
7
Advances in the Post-coronary Artery Bypass Graft Management of Occlusive Coronary Artery Disease.冠状动脉搭桥术后闭塞性冠状动脉疾病管理的进展
Interv Cardiol. 2021 Dec 24;16:e33. doi: 10.15420/icr.2021.12. eCollection 2021 Apr.
8
Diagnostic and Prognostic Value of miRNAs after Coronary Artery Bypass Grafting: A Review.冠状动脉搭桥术后微小RNA的诊断和预后价值:综述
Biology (Basel). 2021 Dec 19;10(12):1350. doi: 10.3390/biology10121350.
9
Early postoperative bleeding impacts long-term survival following first-time on-pump coronary artery bypass grafting.首次体外循环冠状动脉旁路移植术后早期出血影响长期生存。
J Thorac Dis. 2021 Oct;13(10):5670-5682. doi: 10.21037/jtd-21-1241.
10
Tissue engineered bovine saphenous vein extracellular matrix scaffolds produced via antigen removal achieve high in vivo patency rates.经抗原去除处理的组织工程化牛隐静脉细胞外基质支架可实现高体内通畅率。
Acta Biomater. 2021 Oct 15;134:144-159. doi: 10.1016/j.actbio.2021.06.034. Epub 2021 Jun 27.

本文引用的文献

1
Angiographic outcomes of radial artery versus saphenous vein in coronary artery bypass graft surgery: a meta-analysis of randomized controlled trials.经皮冠状动脉旁路移植术桡动脉与隐静脉血管造影结果的比较:一项随机对照试验的荟萃分析。
J Thorac Cardiovasc Surg. 2013 Aug;146(2):255-61. doi: 10.1016/j.jtcvs.2012.07.014. Epub 2012 Aug 4.
2
Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study).冠状动脉旁路移植术后 5 年以上桡动脉和隐静脉通畅情况:RAPS(桡动脉通畅研究)的结果。
J Am Coll Cardiol. 2012 Jul 3;60(1):28-35. doi: 10.1016/j.jacc.2012.03.037.
3
Survival benefit of multiple arterial grafting in a 25-year single-institutional experience: the importance of the third arterial graft.25 年单中心经验:多支动脉搭桥的生存获益:第三支动脉桥的重要性。
Eur J Cardiothorac Surg. 2012 Aug;42(2):284-90; discussion 290-1. doi: 10.1093/ejcts/ezr302. Epub 2012 Jan 26.
4
Propensity matched analysis of bilateral internal mammary artery versus single left internal mammary artery grafting at 17-year follow-up: validation of a contemporary surgical experience.17 年随访时双侧内乳动脉与单支左内乳动脉旁路移植术的倾向性匹配分析:当代手术经验的验证。
Eur J Cardiothorac Surg. 2012 Apr;41(4):770-5; discussion 776. doi: 10.1093/ejcts/ezr213. Epub 2012 Jan 20.
5
Bilateral internal thoracic artery grafting improves long-term survival in patients with reduced ejection fraction: a propensity-matched study with 30-year follow-up.双侧内乳动脉搭桥可改善射血分数降低患者的长期生存率:一项 30 年随访的倾向性匹配研究。
J Thorac Cardiovasc Surg. 2012 Apr;143(4):844-853.e4. doi: 10.1016/j.jtcvs.2011.12.026. Epub 2012 Jan 14.
6
The right internal thoracic artery: the forgotten conduit--5,766 patients and 991 angiograms.右内乳动脉:被遗忘的移植物——5766 例患者和 991 例造影。
Ann Thorac Surg. 2011 Jul;92(1):9-15; discussion 15-7. doi: 10.1016/j.athoracsur.2011.03.099.
7
Systematic comparison of the effectiveness of radial artery and saphenous vein or right internal thoracic artery coronary bypass grafts in non-left anterior descending coronary arteries.非左前降支冠状动脉中桡动脉与隐静脉或右内乳动脉旁路移植桥的有效性的系统比较。
J Zhejiang Univ Sci B. 2011 Apr;12(4):273-9. doi: 10.1631/jzus.B1000241.
8
Radial artery grafts vs saphenous vein grafts in coronary artery bypass surgery: a randomized trial.冠状动脉旁路移植术中桡动脉移植物与隐静脉移植物的比较:一项随机试验。
JAMA. 2011 Jan 12;305(2):167-74. doi: 10.1001/jama.2010.1976.
9
Radial artery versus saphenous vein conduits for coronary artery bypass surgery: forty years of competition--which conduit offers better patency? A systematic review and meta-analysis.桡动脉与隐静脉在冠状动脉旁路移植术中的应用:四十年的竞争——哪种移植物具有更好的通畅率?系统评价和荟萃分析。
Eur J Cardiothorac Surg. 2011 Jul;40(1):208-20. doi: 10.1016/j.ejcts.2010.11.012. Epub 2010 Dec 16.
10
Radial artery conduits improve long-term survival after coronary artery bypass grafting.桡动脉移植物可改善冠状动脉旁路移植术后的长期生存率。
Ann Thorac Surg. 2010 Oct;90(4):1165-72. doi: 10.1016/j.athoracsur.2010.05.038.

冠状动脉旁路移植术用动脉移植物的现状。

Current status of arterial grafts for coronary artery bypass grafting.

机构信息

Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, Oxford, UK.

出版信息

Ann Cardiothorac Surg. 2013 Jul;2(4):427-30. doi: 10.3978/j.issn.2225-319X.2013.07.21.

DOI:10.3978/j.issn.2225-319X.2013.07.21
PMID:23977618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3741887/
Abstract

For over a decade there has been accumulating evidence that the use of more than a single arterial graft during coronary artery bypass grafting can improve clinical outcomes. However the vast majority of patients in most developed countries still only receive a single arterial conduit even in the presence of multivessel coronary artery disease. This review summarizes the current evidence for the use of a second internal mammary artery and/or radial artery graft. While in comparison to vein grafts the superior patency of internal mammary artery grafts is well established, there now exists strong and consistent evidence of the superior patency of radial arteries over the longer term. Likewise, there is a rapidly growing body of evidence that the superior patency of both these arteries in comparison to vein grafts translates into improved clinical outcomes.

摘要

十多年来,越来越多的证据表明,在冠状动脉旁路移植术中使用超过一根动脉移植物可以改善临床结果。然而,在大多数发达国家,即使存在多支冠状动脉疾病,绝大多数患者仍然只接受单一的动脉导管。这篇综述总结了使用第二根乳内动脉和/或桡动脉移植物的现有证据。虽然与静脉移植物相比,乳内动脉移植物的通畅性明显更好,但现在有强有力且一致的证据表明,桡动脉的长期通畅性优于静脉移植物。同样,越来越多的证据表明,与静脉移植物相比,这两种动脉的通畅性更好,可转化为临床结果的改善。